跳至主要内容
临床试验/JPRN-UMIN000052731
JPRN-UMIN000052731已完成Unknown

Safety evaluation for quasi-drug use at HIFU treatment site for the facial sagging - Safety evaluation for quasi-drug use at HIFU treatment site for the facial sagging

POLA Chemical Industries,Inc.0 个研究点目标入组 24 人开始时间: 2023年11月9日最近更新:
适应症

试验速览

阶段
Unknown
状态
已完成
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 54years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • (1) Persons who have skin symptoms such as external wound, acne, eczema, etc. on the face (from the eyebrows to the chin) (2) Persons who have a history of surgery or injections (filler or metal) on the face (from eyebrows to chin tip) (3) Persons who have undergone cosmetic surgery in the past and are currently in the downtime period (4) Persons who have experienced severe pain, erythema, or scarring after undergoing cosmetic surgery in the past (5) Persons who have undergone cosmetic medical surgery (laser irradiation, photofacial, injection therapy, HIFU, incision, thread lift, etc.) that affect the shape and/or color tone of the face (6) Persons with a history of atopic dermatitis (7) Persons with allergies to disinfectant alcohol and/or rubber (8) Persons who are taking medicines (anticoagulants, etc.) that may affect the HIFU treatment (9) Persons who are pregnant, lactating, or planning to become pregnant during the study period (10) Persons who drink alcohol excessively on a regular basis (11) Persons who regularly go or plan to go to tanning salons or plan to do so during the study period (12) Persons who are expected to suffer from severe hay fever* during the study period (*level requiring a hospital visit) (13) Persons who are likely to be exposed to significant sunlight during the study period (e.g., Daily exercise during the daytime) (14) Persons with a history of serious hepatic disorder, renal disorder, or myocardial infarction (15) Persons with severe anemia (* Persons who have been to the hospital multiple times in the past due to anemia) (16) Persons receiving hormone replacement therapy (17) Persons who are currently participating in another clinical study or will participate in another clinical study during the study period (18) Persons with fever (*Exclusion criteria only on the day of the visit. Temperature will be taken at the reception desk) (19) Other persons deemed inappropriate by the research physician

研究者

相似试验